Vertex (VRTX) PT Raised to $235 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Vertex (VRTX) PT Raised to $247 at Piper Jaffray
October 31, 2019 4:26 AM EDTPiper Jaffray analyst Edward Tenthoff raised the price target on Vertex (NASDAQ: VRTX) to $247.00 (from $230.00) while maintaining a Overweight rating.... More
Vertex Pharma (VRTX) Tops Q3 EPS by 8c; Offers FY19 Revenue Outlook
October 30, 2019 4:08 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $1.23, $0.08 better than the analyst estimate of $1.15. Revenue for the quarter came in at $950 million versus the consensus estimate of $950.9 million.
"2019 has been a year of significant progress for Vertex across all parts of our... More



